Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2491 to 2505 of 8906 results

  1. SEEG-guided radiofrequency thermocoagulation in refractory epilepsy

    Topic prioritisation

  2. Transverse Tibial Transport

    Topic prioritisation

  3. Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 13 February 2026.

  4. Guidance on the use of electroconvulsive therapy: review proposal consultation

    We are listening to your views on this Technology appraisal guidance. Comments close 16 February 2026.

  5. Orforglipron for managing overweight and obesity ID6516

    In development Reference number: GID-TA11650 Expected publication date: TBC

  6. Denecimig (Mim8) for preventing bleeding episodes in haemophilia A in people of any age [ID6400]

    Awaiting development Reference number: GID-TA11509 Expected publication date: TBC

  7. Lifileucel for previously treated unresectable or metastatic melanoma ID3863

    In development Reference number: GID-TA10752 Expected publication date:  10 July 2026

  8. Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]

    In development Reference number: GID-TA11572 Expected publication date:  21 May 2026

  9. AHEAD implants for external ear prosthesis

    Topic prioritisation

  10. Intradiscal oxygen-ozone treatment of symptomatic lumbar disc herniation

    Topic prioritisation

  11. Insertion of Stoma Preservation Device

    Topic prioritisation

  12. Botulinum Toxin injection prior to Abdominal wall reconstruction

    Topic prioritisation

  13. Head injury (QS74) update

    In development Reference number: GID-QS10189 Expected publication date:  07 January 2027

  14. Osteoporosis

    In development Reference number: GID-QS10188 Expected publication date: TBC

  15. Rozanolixizumab for treating antibody-positive generalised myasthenia gravis [ID5092]

    In development Reference number: GID-TA10994 Expected publication date: TBC